Immune tolerance Immune clearance Low replication phase Reactivation phase HBeAg ( HBV DNA HBeAg (- anti-HBe ( (Precore/core promoter variant) 2000 IU/mL < 2000 IU/mL 8 11 2 x 10 - 2 x 10 IU/mL 200,000 - 2 x 10 9 IU/mL ALT Chronic hepatitis: None/mild Chronic hepatitis: moderate/severe Chronic ...
We found that the proportion of men did not differ between the group of patients with virological response and the group without virological response (p 0.05) (Table 3.25). This result is similar to some authors in the world [161]. Univariate logistic regression analysis did not show any ...
96. Lin B. et al. (2013), Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice , Journal of Gastroenterology and Hepatology . 28(5), pages 855-860. 97. Lin CL and Kao JH (2008), Hepatitis B viral factors and clinical outcomes of ...
